Pharming Investor Day 2026

February 3, 2026 - 10:00 am EST (16:00 CET)

Please confirm your attendance by January 30, 2026

Additional agenda details and logistical information will be shared in advance of the event.

For those not able to join the live webcast, a recording will be made available on our website after the event.

Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day

Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS

Cookies: Deze website maakt gebruik van cookies. Bekijk de cookie instellingen pagina voor meer informatie Accepteren Weigeren

Taal aanpassen